26th April, 2018


According to the World Health Organization, “A counterfeit medicine is one which is deliberately and fraudulently mislabelled with respect to identity and/or source.”

Dr. Roshan Parasram

Dr. Roshan Parasram

MBBS, PG Dip Public Health, MPH, dLSHTM, FRSPH Chief Medical Officer

Open Remarks

I am a physician and public health consultant working as the Chief Medical Officer (CMO) of Trinidad and Tobago.

In my capacity as CMO, I am the national focal point as it relates to the International Health Regulations. I also serve as the Quarantine Authority for Trinidad and Tobago, and I am a member of the Medical Board of Trinidad and Tobago.

Mr. Percival A. Jordan

Mr. Percival A. Jordan

Pfizer Security Consultant

A Manufacturer / Distributor Perspective on Counterfeiting

Mr. Percival A. Jordan, retired as Supervisory Special Agent, in 2003 from the United Customs Service/U.S. Department of Homeland Security with over 30 years in U.S Federal Law Enforcement service, where he served as Assistant Attache, and Customs Attache at the U.S. Embassy in Venezuela, with responsibilities for Ecuador, Peru, Ecuador, Suriname, Guyana, French Guyana, etc. In conjunction with these countries, he has worked continuously in Central America, and the Caribbean.

Prof. Francisco Donadío, RPh, MHSM. MSc

Prof. Francisco Donadío, RPh, MHSM. MSc

Product Patrimony Management Head for Pacific, Central America and the Caribbean, Sanofi

Pharmaceutical Counterfeiting – A Global Treat

Topic Summary: Counterfeit drugs are harmful for human health. The fact that these products are made to make profit out of human lives, makes this business a crime. We need to know what are they, how they might be manufactured, how harmful they can be, how much profit they can make but also how we can fight against them, towards awareness, education and some tips on how they can be recognized.

  • Pharmaceutical Counterfeiting – A Global Threat (Issues & Trends)
  • The Caribbean Story – The Role of Governmental Agencies in Drug Counterfeiting
  • Challenges to Patient Safety – Drug Availability & Online Purchasing
  • New Technologies for Identifying Counterfeit Drugs
  • The Role of Patients, Doctors, Pharmacists and Caregivers
  • Combating the Counterfeiters – Managing the Problem
  • A Manufacturers’ /Distributors Perspective on Counterfeiting
  • Impact on Medical Tourism
  • Standardization, Measurement & Quality Assurance
  • Many fake medicines are dummies deliberately created to resemble genuine drugs. Often they are utterly devoid of any active ingredient — but sometimes they may contain harmful or poisonous chemicals.
  • One million people die from fake drugs every year.
  • The trade in counterfeit drugs has grown into a global industry worth billions of dollars, targeting mostly developing countries.
  • Public health experts believe poor regulatory and surveillance systems in the developing world mean the problem is even more widespread than it seems.
  • 237 people were arrested worldwide and 10,603 websites that were selling counterfeit medicines were shut down in 2014.
  • The prescription drug market is vast and lucrative – up to $900 billion worldwide annually.
  • More than 30% of the counterfeit drugs that are available today don’t contain any active ingredients whatsoever.
  • Counterfeit Pharmaceuticals are illegal and pose a serious threat to Patient Safety: Pharmaceutical counterfeiting is on the rise in the United States and around the globe, potentially putting at risk the health of millions of patients who take for granted that the prescription medicines they buy are safe and effective.
  • Counterfeit drugs deny patients treatment that can alleviate suffering and save lives.
  • Counterfeit drugs promote drug resistant strains of diseases.
  • Counterfeit drugs may cause reactions with undeclared drug ingredients or toxic poisoning.


© Copyright - CARIRI Pharmaceutical Counterfeit Conference 2018